Home › Funds › Invenomic Capital Management LP › ST
Invenomic Capital Management LP position in ST
SENSATA TECHNOLOGIES HLDG PL · Industrials
Invenomic Capital Management LP reported holding 1,493,441 shares of ST (SENSATA TECHNOLOGIES HLDG PL) in its Q3 2026 13F filing — a position valued at US$62.1M, representing 3.07% of its reported portfolio and ranking #4 among its reported holdings. Invenomic Capital Management LP has disclosed ST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's ST position evolved
Invenomic Capital Management LP first disclosed a stake in ST in Q3 2023 at 318,000 shares (US$12.0M). The position peaked in Q3 2026 at 1,493,441 shares, worth US$62.1M. Across 13 filings, Invenomic Capital Management LP increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,493,441 shares valued at US$62.1M — an increase of 1,023,219 shares quarter over quarter.. Notable position changes include a 91% increase in Q1 2024 (shares rose 2% over the following quarter), a 52% increase in Q1 2025 (shares rose 24% over the following quarter), a 218% increase in Q3 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 318.00K | $12.03M | New |
| Q4 2023 | 459.94K | $17.28M | Add |
| Q1 2024 | 879.19K | $32.30M | Add |
| Q2 2024 | 764.41K | $28.58M | Reduce |
| Q3 2024 | 857.67K | $30.76M | Add |
| Q4 2024 | 1.04M | $28.61M | Add |
| Q1 2025 | 1.58M | $38.45M | Add |
| Q2 2025 | 1.19M | $35.94M | Reduce |
| Q3 2025 | 1.17M | $35.81M | Reduce |
| Q4 2025 | 1.22M | $40.53M | Add |
| Q1 2026 | 950.29K | $33.47M | Reduce |
| Q2 2026 | 470.22K | $22.45M | Reduce |
| Q3 2026 | 1.49M | $62.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ST and 13F data
ST (SENSATA TECHNOLOGIES HLDG PL) is a Industrials company. 28 other funds we track also report a position in ST — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$243.6M), Woodline Partners LP (US$111.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ST
- FULLER & THALER ASSET MANAGEMENT, INC. 5.86M sh · $243.59M · Q3 2026
- Woodline Partners LP 2.68M sh · $111.35M · Q3 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held ST?
Invenomic Capital Management LP has disclosed ST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Invenomic Capital Management LP's current position in ST?
As of Q3 2026, Invenomic Capital Management LP holds 1.49M shares of ST (SENSATA TECHNOLOGIES HLDG PL), valued at $62.07M, representing 3.07% of its reported portfolio and ranking #4.
Has Invenomic Capital Management LP been buying or selling ST?
In the latest 13F filing (Q3 2026), Invenomic Capital Management LP increased its position in ST. The position peaked in Q3 2026 at 1.49M shares.
Which other funds hold ST?
Other major institutional holders of ST include FULLER & THALER ASSET MANAGEMENT, INC., Woodline Partners LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.